Haematopoietic stem cell transplantation for patients with ... - PubMed
pubmed.ncbi.nlm.nih.gov › ...
Allogeneic stem cell transplantation from an HLA-identical sibling donor is a curative treatment option for a young patient with myelodysplastic syndrome.
Hematopoietic cell transplantation (HCT) is an effective treatment for myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML).
Missing: Haematopoietic Leukaemia
This report describes an analysis of the data from 1378 patients transplanted for MDS or secondary acute myeloid leukaemia (MDS-AML). We focused on prognostic ...
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the chronic ...
Dec 24, 2001 · Allogeneic stem cell transplantation from an HLA-identical sibling donor is a curative treatment option for a young patient with myelodysplastic ...
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondry acute myeloid leukaemias: A report on behalf of the ...
People also ask
What is the survival rate for AML stem cell transplant?
What is the life expectancy of a stem cell transplant for MDS?
What is hematopoietic stem cells transplantation in leukemia?
What is haematopoietic stem cell transplantation for autoimmune diseases?
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: a report on behalf of the Chronic ...
Missing: Leukaemia | Show results with:Leukaemia
Allogeneic stem cell transplantation is a potentially curative treatment for myelodysplastic syndromes. Transplants are clearly indicated in patients with ...
This document addresses hematopoietic stem cell transplantation (HSCT) or hematopoietic cell transplant (HCT) in the treatment of the following select ...
Allogeneic hematopoietic stem cell transplantation remains the only curative option for myelodysplastic syndrome, but patients with this disease are often ...